Pachito Daniela V, Longato Mauricio, Cordeiro Guilherme, Almeida Paulo H R F, Ferreira Ricardo Macarini, Burian Ana Paula N
Pfizer Brazil, São Paulo, SP, Brazil.
Analytix, São Paulo, SP, Brazil.
Braz J Infect Dis. 2025 Jan-Feb;29(1):104482. doi: 10.1016/j.bjid.2024.104482. Epub 2024 Nov 27.
Community-Acquired Pneumonia (CAP) caused by pneumococcus and Invasive Pneumococcal Disease (IPD) pose a substantial economic burden on health systems. The objective of the present study is to explore hospitalization costs of pneumococcal disease in the public health system in Brazil, the Unified Health System.
Retrospective analysis of administrative data on hospitalized cases of pneumococcal disease from January 2019 to July 2023. Hospitalization cases recorded with ICD-10 codes of CAP due to S. pneumoniae and IPD were retrieved from DATASUS, the inpatient information system of the Unified Health System in Brazil. Costs were converted to US dollars by Using Purchasing Power Parity (USD-PPP). Absolute number of hospitalizations, costs of hospitalizations and healthcare resource utilization were presented descriptively. The annual cost estimate was calculated. Differences in costs by type of clinical presentation and age group were assessed. Factors associated with higher costs were explored by multiple linear regression models.
A total of 22,498 hospitalization episodes were analyzed. Total cost of hospitalizations was USD-PPP 13,958,959 (BRL 34,659,578) with an annual mean estimate of USD-PPP 3,045,591 (BRL 7,562,090). Cost per hospitalization episode was significantly higher for meningitis, followed by septicemia, CAP and arthritis, with median values ranging from USD-PPP 190.93 to 615.14 (BRL 476.20 to 1529.02). (Kruskal-Wallis χ = 6473, df = 3, p-value < 0.0001). Costs were significantly higher among individuals aged 60-years and older. (Kruskal-Wallis test; χ = 773.53; df = 2, p-value < 0.0001). There were differences in age at hospitalization, length of stay, and ICU utilization among types of clinical presentations.
Our findings reveal the economic burden associated with pneumococcal disease in the Unified Health System in Brazil. Hospitalization costs were higher for cases of meningitis and among individuals aged 60-years and above.
由肺炎球菌引起的社区获得性肺炎(CAP)和侵袭性肺炎球菌病(IPD)给卫生系统带来了巨大的经济负担。本研究的目的是探讨巴西统一卫生系统中肺炎球菌病的住院费用。
对2019年1月至2023年7月肺炎球菌病住院病例的行政数据进行回顾性分析。从巴西统一卫生系统的住院患者信息系统DATASUS中检索记录有因肺炎链球菌导致的CAP和IPD的ICD-10编码的住院病例。使用购买力平价(USD-PPP)将成本换算为美元。对住院的绝对数量、住院费用和医疗资源利用情况进行描述性呈现。计算年度成本估计值。评估不同临床表现类型和年龄组的成本差异。通过多元线性回归模型探索与较高成本相关的因素。
共分析了22498例住院病例。住院总费用为13958959美元购买力平价(34659578巴西雷亚尔),年度平均估计值为3045591美元购买力平价(7562090巴西雷亚尔)。脑膜炎的每次住院费用显著更高,其次是败血症、CAP和关节炎,中位数范围从190.93美元到615.14美元购买力平价(476.20巴西雷亚尔到1529.02巴西雷亚尔)。(Kruskal-Wallis χ = 6473,自由度 = 3,p值 < 0.0001)。60岁及以上人群的成本显著更高。(Kruskal-Wallis检验;χ = 773.53;自由度 = 2,p值 < 0.0001)。不同临床表现类型在住院年龄、住院时间和ICU使用方面存在差异。
我们的研究结果揭示了巴西统一卫生系统中与肺炎球菌病相关的经济负担。脑膜炎病例以及60岁及以上人群的住院费用更高。